Fralin Biomedical Research Institute at VTC
Roanoke, Virginia, 24016, United States
NCT Number: NCT06017986
The minimally processed diets of our ancestors have been rapidly replaced by UPFs driving poor diet to become the leading risk factor for preventable death globally. Hence, it is essential to understand what properties of UPF are driving their overconsumption to reduce diet-related mortality. To address this gap in knowledge this proposal will test:
* If UPFs have a greater post meal metabolic response when compared to MPFs an essential signal for food reward * Through the use of an auction task paradigm if UPFs overvalued and if this value is differentially encoded in the brain This study is a fully cross-over design in that each participant receives all conditions and therefore serves as their own control. All orders of foods will be counterbalanced. Although participants cannot be blinded to the conditions as they must be aware of the foods they are eating, they will not be made aware that the key manipulation is food processing. On different days participants will come to the lab and consume a meal containing either minimally or ultra-processed foods as determined by the widely used NOVA (not an acronym) scale. These conditions will be consumed in a whole room metabolic chamber allowing for simultaneous measurement of multiple metabolic responses (glucose, insulin, and metabolic rate). These measures will be collected for 45 min before consumption of the meal (baseline) and for 3 hours after consumption (post-prandial). All participants will also undergo a Becker-Degroot-Marschak auction paradigm that consists of foods that are either minimally or Ultra-processed in the MRI scanner. Food value will be measure in participants' willingness to pay for each food and Neural responses will be measured during presentation of the food cues.
Looking for future studies?
Notify Me18 year–45 year
All sexes
Interventional
Not applicable
Roanoke, Virginia, 24016, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A meal containing ultra-processed foods derived from the picture set used in the Becker-Degroot-Marschak auction paradigm.
a meal containing minimally processed foods derived from the picture set used in the Becker-Degroot-Marschak auction paradigm.
Time frame: Immediately post intervention
Blood glucose concentration will be assessed at baseline and at set time points for 3 hours after consumption of each condition on different days.
Time frame: Immediately post intervention
Blood insulin concentration will be assessed at baseline and at set time points for 3 hours after consumption of each condition on different days.
Time frame: Immediately post intervention
Whole room indirect calorimetry will be used to determine energy expenditure at baseline and for 3 hours after consumption of each condition on different days.
Time frame: Immediately post intervention
Whole room indirect calorimetry will be used to determine respiratory exchange ratio at baseline and for 3 hours after consumption of each condition on different days.
Time frame: Immediately post intervention
Whole room indirect calorimetry will be used to determine substrate oxidation at baseline and for 3 hours after consumption of each condition on different days.
Time frame: through study completion, an average of 3 weeks
A food picture set of 28 that are matched on 26 visual, perceptual, and nutritional properties but vary on degree of NOVA food processing level will be used in a Becker-Degroot-Marschak auction paradigm to assess participants' brain reward response for each food.
Virginia Polytechnic Institute and State University
Other
Metabolic and Physiological Effects of Processing on Food Reward Encoding
Acronym: PFR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07716579
Brain Diseases, Brain Neoplasms
Ljubljana, Slovenia
View Trial DetailsNCT07646015
Diabetes Mellitus, Diabetes Mellitus, Type 2
Mysore, Karnataka, India
View Trial DetailsNCT04958109
Metabolic Diseases, Nutritional and Metabolic Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT06619834
Diabetes Mellitus, Endocrine System Diseases
Ann Arbor, Michigan, United States
View Trial Details